Insulin-like growth factor-I and neurogenesis in the adult mammalian brain - PubMed (original) (raw)

Review

Insulin-like growth factor-I and neurogenesis in the adult mammalian brain

Michelle F Anderson et al. Brain Res Dev Brain Res. 2002.

Abstract

In most brain regions of highly developed mammals, the majority of neurogenesis is terminated soon after birth. However, new neurons are continually generated throughout life in the subventricular zone and the dentate gyrus of the hippocampus. Insulin-like growth factor-I (IGF-I) is a polypeptide hormone that has demonstrated effects on these progenitor cells. IGF-I induces proliferation of isolated progenitors in culture, as well as affecting various aspects of neuronal induction and maturation. Moreover, systemic infusion of IGF-I increases both proliferation and neurogenesis in the adult rat hippocampus, and uptake of serum IGF-I by the brain parenchyma mediates the increase in neurogenesis induced by exercise. Neurogenesis in the adult brain is regulated by many factors including aging, chronic stress, depression and brain injury. Aging is associated with reductions in both hippocampal neurogenesis and IGF-I levels, and administration of IGF-I to old rats increases neurogenesis and reverses cognitive impairments. Similarly, stress and depression also inhibit neurogenesis, possibly via the associated reductions in serotonin or increases in circulating glucocorticoids. As both of these changes have the potential to down regulate IGF-I production by neural cells, stress may inhibit neurogenesis indirectly via downregulation of IGF-I. In contrast, brain injury stimulates neurogenesis, and is associated with upregulation of IGF-I in the brain. Thus, there is a tight correlation between IGF-I and neurogenesis in the adult brain under different conditions. Further studies are needed to clarify whether IGF-I does indeed mediate neurogenesis in these situations.

PubMed Disclaimer

Cited by

SUMOylation of Warts kinase promotes neural stem cell reactivation.
Gao Y, Tan YS, Lin J, Chew LY, Aung HY, Palliyana B, Gujar MR, Lin KY, Kondo S, Wang H. Gao Y, et al. Nat Commun. 2024 Oct 17;15(1):8557. doi: 10.1038/s41467-024-52569-y. Nat Commun. 2024. PMID: 39419973 Free PMC article.
Psychopharmacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorders.
Matar D, Serhan A, El Bilani S, Faraj RA, Hadi BA, Fakhoury M. Matar D, et al. Adv Exp Med Biol. 2024;1456:27-48. doi: 10.1007/978-981-97-4402-2_2. Adv Exp Med Biol. 2024. PMID: 39261422 Review.
Astrocytes control quiescent NSC reactivation via GPCR signaling-mediated F-actin remodeling.
Lin KY, Gujar MR, Lin J, Ding WY, Huang J, Gao Y, Tan YS, Teng X, Christine LSL, Kanchanawong P, Toyama Y, Wang H. Lin KY, et al. Sci Adv. 2024 Jul 26;10(30):eadl4694. doi: 10.1126/sciadv.adl4694. Epub 2024 Jul 24. Sci Adv. 2024. PMID: 39047090 Free PMC article.
The neurobiology of insulin-like growth factor I: From neuroprotection to modulation of brain states.
Nuñez A, Zegarra-Valdivia J, Fernandez de Sevilla D, Pignatelli J, Torres Aleman I. Nuñez A, et al. Mol Psychiatry. 2023 Aug;28(8):3220-3230. doi: 10.1038/s41380-023-02136-6. Epub 2023 Jun 23. Mol Psychiatry. 2023. PMID: 37353586 Review.
Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression.
Borsellino P, Krider RI, Chea D, Grinnell R, Vida TA. Borsellino P, et al. Pharmaceuticals (Basel). 2023 May 12;16(5):742. doi: 10.3390/ph16050742. Pharmaceuticals (Basel). 2023. PMID: 37242525 Free PMC article. Review.

Insulin-like growth factor-I and neurogenesis in the adult mammalian brain - PubMed (original) (raw)